Kumara Vadivel Subramanian

Title: Kumara Vadivel Subramanian: Innovator in N-acylethanolamine Hydrolyzing Acid Amidase Inhibitors

Introduction

Kumara Vadivel Subramanian is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for N-acylethanolamine hydrolyzing acid amidase (NAAA). With a total of 2 patents to his name, his work is paving the way for advancements in therapeutic applications.

Latest Patents

Subramanian's latest patents focus on N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors. These patents describe compounds represented as Formula I, which include tautomeric and stereoisomeric forms, as well as pharmaceutically acceptable salts. The compounds of Formula I are recognized as effective inhibitors of NAAA, which plays a crucial role in various physiological processes. The technology aims to provide compounds, compositions, and methods to inhibit NAAA and treat conditions mediated by this enzyme.

Career Highlights

Kumara Vadivel Subramanian is affiliated with Northeastern University, where he continues to engage in innovative research. His work has garnered attention for its potential impact on medical treatments and drug development.

Collaborations

Some of his notable coworkers include Michael Sotirios Malamas and Alexandros Makriyannis, who contribute to the collaborative research environment at Northeastern University.

Conclusion

Kumara Vadivel Subramanian's contributions to the field of biochemistry, particularly through his patents on NAAA inhibitors, highlight his role as an influential inventor. His work not only advances scientific understanding but also holds promise for future therapeutic applications.